Literature DB >> 1755649

New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.

A Malfroot1, I Dab.   

Abstract

A higher frequency (25%) of gastrooesophageal reflux (GOR) has been previously reported in patients over 5 years old with cystic fibrosis compared with controls without cystic fibrosis. It was believed that GOR was caused by the complications of cystic fibrosis. We looked for GOR in all 26 children younger than 60 months who had cystic fibrosis diagnosed. They had a classical genetic profile and the usual scattered clinical manifestations for age. GOR was confirmed in 21 (81%): 20 by abnormal pH tracings and in one on a clinical basis. After at least one month of adjusted cystic fibrosis treatment, antireflux treatment (cisapride) was given to 16 patients and variables of GOR improved dramatically. Weight gain was significant and recurrent cough and wheeze disappeared. One year later half of the patients still suffered from GOR. GOR is a major problem in the early life of those with cystic fibrosis and is not the consequence of either respiratory or gastrointestinal complications as it improves with age whereas cystic fibrosis becomes worse with age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755649      PMCID: PMC1793275          DOI: 10.1136/adc.66.11.1339

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

1.  Gastro-oesophageal scintiscanning in children.

Authors:  A Piepsz; B Georges; N Perlmutter; P Rodesch; S Cadranel
Journal:  Pediatr Radiol       Date:  1981

2.  Patterns of gastroesophageal reflux in health and disease.

Authors:  T R Demeester; L F Johnson; G J Joseph; M S Toscano; A W Hall; D B Skinner
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

3.  Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.

Authors:  S Cucchiara; A Staiano; A Boccieri; M De Stefano; C Capozzi; G Manzi; F Camerlingo; F M Paone
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

4.  Gastroesophageal (GE) scintiscanning to detect and quantitate GE reflux.

Authors:  R S Fisher; L S Malmud; G S Roberts; I F Lobis
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  Gastroesophageal reflux-associated recurrent pneumonia and chronic asthma in children.

Authors:  W E Berquist; G S Rachelefsky; M Kadden; S C Siegel; R M Katz; E W Fonkalsrud; M E Ament
Journal:  Pediatrics       Date:  1981-07       Impact factor: 7.124

6.  Complications of gastroesophageal reflux in patients with cystic fibrosis.

Authors:  D W Bendig; D K Seilheimer; M L Wagner; G D Ferry; G M Barrison
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

7.  Mechanisms of gastroesophageal reflux in children.

Authors:  S L Werlin; W J Dodds; W J Hogan; R C Arndorfer
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

8.  Recurrent pulmonary disease in children: a complication of gastroesophageal reflux.

Authors:  A R Euler; W J Byrne; M E Ament; E W Fonkalsrud; C T Strobel; S C Siegel; R M Katz; G S Rachelefsky
Journal:  Pediatrics       Date:  1979-01       Impact factor: 7.124

9.  Gastroesophageal reflux.

Authors:  J J Herbst
Journal:  J Pediatr       Date:  1981-06       Impact factor: 4.406

10.  Gastroesophageal reflux in the infant with cystic fibrosis.

Authors:  C D Vinocur; L Marmon; D V Schidlow; W H Weintraub
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

View more
  15 in total

1.  Varicella: to vaccinate or not to vaccinate?

Authors:  A Gershon
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 2.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 3.  The relationship between percutaneous endoscopic gastrostomy and gastro-oesophageal reflux disease in children: a systematic review.

Authors:  Louise J Noble; A Mark Dalzell; Wael El-Matary
Journal:  Surg Endosc       Date:  2012-03-22       Impact factor: 4.584

4.  The risks and benefits of cisapride in premature neonates, infants, and children.

Authors:  A Lander; A Desai
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 5.  Abdominal pain in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

6.  Electrogastrography in children with cystic fibrosis.

Authors:  Atiye Nur Aktay; Mark L Splaingard; Tami Miller; Mary Ellen Freeman; Heidi Hoeppner; Steven L Werlin
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

7.  Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis.

Authors:  B M Button; R G Heine; A G Catto-Smith; P D Phelan; A Olinsky
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

Review 8.  Gastroesophageal reflux in cystic fibrosis: current understandings of mechanisms and management.

Authors:  Hayat M Mousa; Frederick W Woodley
Journal:  Curr Gastroenterol Rep       Date:  2012-06

Review 9.  Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments.

Authors:  Louise Lannefors; Brenda M Button; Maggie McIlwaine
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

Review 10.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.